MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed cash
Cash and short-term investments held at the end of each period.
MariMed's cash was $10.36M at Sep 30, 2026. For fiscal 2025 it was $8.88M, up 22.0% from the year before. Over ten years it grew 49.4% a year on average. The highest annual figure on record is $29.93M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.88M | +22.0% |
| FY2024 | Dec 31, 2024 | $7.28M | -50.6% |
| FY2023 | Dec 31, 2023 | $14.73M | +49.4% |
| FY2022 | Dec 31, 2022 | $9.86M | -67.1% |
| FY2021 | Dec 31, 2021 | $29.93M | +587.2% |
| FY2020 | Dec 31, 2020 | $4.36M | +99.1% |
| FY2019 | Dec 31, 2019 | $2.19M | -46.7% |
| FY2018 | Dec 31, 2018 | $4.10M | +218.1% |
| FY2017 | Dec 31, 2017 | $1.29M | +126.6% |
| FY2016 | Dec 31, 2016 | $569.36K | +253.9% |
| FY2015 | Dec 31, 2015 | $160.86K | -83.7% |
| FY2014 | Dec 31, 2014 | $988.27K | +11474.9% |
| FY2013 | Dec 31, 2013 | $8.54K | -0.5% |
| FY2012 | Dec 31, 2012 | $8.59K | -92.8% |
| FY2011 | Dec 31, 2011 | $118.80K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $10.36M | +57.1% |
| Q2 FY2026 | Jun 30, 2026 | $8.44M | +37.5% |
| Q1 FY2026 | Mar 31, 2026 | $7.94M | +10.2% |
| Q4 FY2025 | Dec 31, 2025 | $8.88M | +22.0% |
| Q3 FY2025 | Sep 30, 2025 | $6.60M | -32.6% |
| Q2 FY2025 | Jun 30, 2025 | $6.14M | -39.8% |
| Q1 FY2025 | Mar 31, 2025 | $7.20M | -52.7% |
| Q4 FY2024 | Dec 31, 2024 | $7.28M | -50.6% |
| Q3 FY2024 | Sep 30, 2024 | $9.79M | -27.1% |
| Q2 FY2024 | Jun 30, 2024 | $10.19M | -30.8% |
| Q1 FY2024 | Mar 31, 2024 | $15.23M | -29.8% |
| Q4 FY2023 | Dec 31, 2023 | $14.73M | +49.4% |
| Q3 FY2023 | Sep 30, 2023 | $13.42M | +17.9% |
| Q2 FY2023 | Jun 30, 2023 | $14.74M | +74.7% |
| Q1 FY2023 | Mar 31, 2023 | $21.70M | -37.5% |
| Q4 FY2022 | Dec 31, 2022 | $9.86M | -67.1% |
| Q3 FY2022 | Sep 30, 2022 | $11.39M | -56.2% |
| Q2 FY2022 | Jun 30, 2022 | $8.44M | -38.1% |
| Q1 FY2022 | Mar 31, 2022 | $34.72M | +697.0% |
| Q4 FY2021 | Dec 31, 2021 | $29.93M | +817.1% |
| Q3 FY2021 | Sep 30, 2021 | $26.00M | +732.0% |
| Q1 FY2021 | Mar 31, 2021 | $13.63M | +420.9% |
| Q4 FY2020 | Dec 31, 2020 | $4.36M | +99.1% |
| Q3 FY2020 | Sep 30, 2020 | $3.26M | +2288.0% |
| Q2 FY2020 | Jun 30, 2020 | $3.12M | -11.5% |
| Q1 FY2020 | Mar 31, 2020 | $2.62M | -37.9% |
| Q4 FY2019 | Dec 31, 2019 | $2.19M | -46.7% |
| Q3 FY2019 | Sep 30, 2019 | $136.68K | -97.7% |
| Q2 FY2019 | Jun 30, 2019 | $3.53M | -30.5% |
| Q1 FY2019 | Mar 31, 2019 | $4.22M | +929.3% |
| Q4 FY2018 | Dec 31, 2018 | $4.10M | +218.1% |
| Q3 FY2018 | Sep 30, 2018 | $6.03M | +823.0% |
| Q2 FY2018 | Jun 30, 2018 | $5.08M | +80.3% |
| Q1 FY2018 | Mar 31, 2018 | $409.59K | -36.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.29M | +126.6% |
| Q3 FY2017 | Sep 30, 2017 | $653.00K | +199.5% |
| Q2 FY2017 | Jun 30, 2017 | $2.82M | – |
| Q1 FY2017 | Mar 31, 2017 | $640.28K | – |
| Q4 FY2016 | Dec 31, 2016 | $569.36K | – |
| Q3 FY2016 | Sep 30, 2016 | $218.04K | – |
See a number that looks wrong?